Contractor (6 Months) Study Coordinator (equivalent level to RA)

> Editas Medicine · Cambridge, United States · Temporary · Posted 2026-06-16

Workplace: on_site

Department: DSTS

Description

At Editas Medicine, we are pioneering the possible. Our mission and commitment is to translate the power and potential of the CRISPR/Cas12a and CRISPR/Cas9 genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world.  Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases.  

Why Choose Editas?

At Editas Medicine, we’re a team of passionate problem solvers, harnessing the power and potential of CRISPR gene editing to transform the future of medicine. Driven by a shared purpose to serve people living with serious diseases, we succeed together through collaboration, mutual respect, and innovation. If you want to be part of a team where your voice is heard and respected, where you can operate at the forefront of gene editing, and push the boundaries of what’s possible in medicine, come join us and become an Editor!

Decoding The Role:

Editas Medicine is seeking a Study Coordinator to join our DMPK, Nonclinical Safety, and Translational Science Team. The Study Coordinator will be integral to supporting the development of our nonclinical pipeline from target nomination to regulatory submission by tracking and coordinating timelines, activities, samples and data within and across functional groups.

Characterizing Your Impact:

As a Study Coordinator in the DMPK, Nonclinical Safety, and Translational Science Team, you will:

• Build, track and manage nonclinical timelines ensuring that activities and deliverables remain on target for meeting program milestones